Patients Related Topics 
MedCity News
JUNE 9, 2024
Hospitals need to start thinking about ways to build patients’ trust in generative AI in order for the healthcare industry to fully harness the technology’s potential. They can do this through methods like having transparent conversations, asking for patients’ consent to use the tools and training models on internal data, experts said.
MedCity News
AUGUST 8, 2024
This potential for self-management can reduce the burden on the healthcare system, resulting in fewer doctor visits, lower hospitalization risks, and fewer diagnostic tests as patients can take corrective action earlier or identify issues sooner.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JUNE 12, 2024
The post Reimagining the Language and Translation Space for Patients appeared first on MedCity News. Lack of adequate translation and interpreting services isn’t just an inconvenience, it is dangerous and potentially life-threatening.
PharmaVoice
MARCH 3, 2025
Next-generation direct-to-patient programs can deliver. Consumers want more from biopharma.
Advertisement
Deviations from the intended supply chain can delay timelines and affect these high value products, which can be detrimental to budgets, but more importantly can have dire effects on the patients whose lives depend on receiving these critical doses safely and on time.
MedCity News
APRIL 24, 2024
Game-changing advances can be achieved by integrating patient collaboration and priorities into the full span of trial design. The post It’s Time to Give Patients a Seat at the Table appeared first on MedCity News.
MedCity News
SEPTEMBER 27, 2024
Artificial intelligence (AI) holds potential to forecast and predict where hospital leaders should direct limited resources such as clinicians, staff, and beds to improve operational efficiency and drive better patient outcomes. The post How AI Can Help Hospitals Overcome Patient Flow Barriers appeared first on MedCity News.
Advertisement
The potential for reaching a larger pool of recruits is possible when sponsors can bring more trial activities to the patient. There’s been a rapid shift towards decentralization in clinical trials & it’s clear why.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven decision-making.
Advertisement
An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays.
Advertisement
Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. Clinical trial data management is increasingly challenging as studies grow in complexity. In this paper, we explore real-time data access and analysis for proactive study management.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development? Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs.
Expert insights. Personalized for you.
356 
Let's personalize your content